Kang Sun

Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial

Xi-Chun Hu, Jian Zhang, Bing-He Xu et al. · The Lancet Oncology · 2015 · 279 citations

First-line Therapy, Breast Oncology, Oncology +7

Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies

Kim Papp, Jacek C. Szepietowski, Leon Kircik et al. · Journal of the American Academy of Dermatology · 2021 · 274 citations

Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial

David Rosmarin, Amit G. Pandya, Mark Lebwohl et al. · The Lancet · 2020 · 241 citations

Ruxolitinib Cream, Medicine, Clinical Dermatology +3

Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo

David Rosmarin, Thierry Passeron, Amit G. Pandya et al. · New England Journal of Medicine · 2022 · 232 citations

Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream

Brian Kim, Michael Howell, Kang Sun et al. · Journal of Allergy and Clinical Immunology · 2019 · 215 citations · Full text